Authors:
LACKNER C
MOSER R
BAUERNHOFER T
WILDERSTRUSCHNIG M
SAMONIGG H
BERGHOLD A
ZATLOUKAL K
Citation: C. Lackner et al., SOLUBLE CD44 V5 AND V6 IN SERUM OF PATIENTS WITH BREAST-CANCER - CORRELATION WITH EXPRESSION OF CD44 V5 AND V6 VARIANTS IN PRIMARY TUMORS AND LOCATION OF DISTANT METASTASIS, Breast cancer research and treatment, 47(1), 1998, pp. 29-40
Authors:
SAMONIGG H
WILDERSTRUSCHNIG M
KUSS I
PLOT R
STOGER H
SCHMID M
BAUERNHOFER T
TIRAN A
HAVELEC L
LOIBNER H
Citation: H. Samonigg et al., IMMUNIZATION WITH ANTIIDIOTYPE VACCINE SCV-106 PROLONGS SURVIVAL-TIMEOF CANCER-PATIENTS WITH METASTATIC COLORECTAL-CANCER - A RANDOMIZED DOUBLE-BLIND CLINICAL-TRIAL, European journal of cancer, 31A, 1995, pp. 45-45
Authors:
LUDWIG H
SUNDAL E
PECHERSTORFER M
LEITGEB C
BAUERNHOFER T
BEINHAUER A
SAMONIGG H
KAPPELER AW
FRITZ E
Citation: H. Ludwig et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE CORRECTION OF CANCER-ASSOCIATED ANEMIA WITH AND WITHOUT CONCOMITANT CYTOTOXIC CHEMOTHERAPY, Cancer, 76(11), 1995, pp. 2319-2329
Authors:
STOGER H
BAUERNHOFER T
SCHMID M
PLONER F
MOSER R
DERSTVENSCHEG E
STEINDORFER P
WILDERSTRUSCHNIG M
KUSS I
SAMONIGG H
Citation: H. Stoger et al., A PHASE-I II STUDY OF 4'-O-TETRAHYDROPYRANYL-DOXORUBICIN, 5-FLUOROURACIL, AND HIGH-DOSE LEUCOVORIN AS FIRST-LINE THERAPY IN ADVANCED BREAST-CANCER PATIENTS/, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 174-178
Authors:
STOGER H
BAUERNHOFER T
KASPAREK AK
SCHMID M
MOSER R
PLONER F
DERSTVENSCHEG E
KUSS I
WILDERSTRUSCHNIG M
STEINDORFER P
ROSANELLI G
SAMONIGG H
Citation: H. Stoger et al., WEEKLY 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID IN COMBINATION WITH EPIDOXORUBICIN AS FIRST-LINE THERAPY IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, Cancer chemotherapy and pharmacology, 34(1), 1994, pp. 75-78
Authors:
STOGER H
SCHMID M
BAUERNHOFER T
MOSER R
PLONER F
DERSTVENSCHEG E
KASPAREK AK
KUSS I
WILDERSTRUSCHNIG M
LACKNER C
STEINDORFER P
SAMONIGG H
Citation: H. Stoger et al., A PHASE-II TRIAL OF WEEKLY HIGH-DOSE FOLINIC ACID AND 5-FLUOROURACIL IN COMBINATION WITH EPIRUBICIN AS SALVAGE CHEMOTHERAPY IN ADVANCED BREAST-CANCER, Oncology, 51(6), 1994, pp. 518-522
Authors:
STOGER H
WILDERSTRUSCHNIG M
SAMONIGG H
SCHMID M
BAUERNHOFER T
TIRAN A
TAS M
DREXHAGE HA
Citation: H. Stoger et al., THE PRESENCE OF IMMUNOSUPPRESSIVE P15E-LIKE FACTORS IN THE SERUM AND URINE OF PATIENTS SUFFERING FROM MALIGN AND BENIGN BREAST-TUMORS, Clinical and experimental immunology, 93(3), 1993, pp. 437-441